Literature DB >> 28385603

Research progress in advanced melanoma.

Cong Luo1, Jiayu Shen2.   

Abstract

Melanoma is a malignant tumor with high rate of metastasis and poor prognosis. How melanoma develops and how to treat it will continue to be a hot topic. This review briefly summarizes the mechanism of melanoma development and the latest progress in its treatment.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Genetic mutation; Melanoma; Treatment

Mesh：

Substances：

Year:  2017        PMID： 28385603     DOI： 10.1016/j.canlet.2017.03.037

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


  11 in total

1.  METTL3-induced UCK2 m6A hypermethylation promotes melanoma cancer cell metastasis via the WNT/β-catenin pathway.

Authors:  Hao Wu; Haochao Xu; Dongdong Jia; Tao Li; Liming Xia
Journal:  Ann Transl Med       Date:  2021-07

2.  Blue light-triggered optogenetic system for treating uveal melanoma.

Authors:  Mingliang Zhang; Xiao Lin; Jinping Zhang; Lin Su; Mingming Ma; Vicki L Ea; Xun Liu; Liming Wang; Jin Chang; Xiaorong Li; Xiaomin Zhang
Journal:  Oncogene       Date:  2019-12-06       Impact factor: 8.756

3.  lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p.

Authors:  Jianwen Long; Xianming Pi
Journal:  Biomed Res Int       Date:  2018-04-02       Impact factor: 3.411

4.  Dual Kit/Aur Inhibitors as Chemosensitizing Agents for the Treatment of Melanoma: Design, Synthesis, Docking Studies and Functional Investigation.

Authors:  Luca Quattrini; Vito Coviello; Stefania Sartini; Teresa Di Desidero; Paola Orlandi; Yi-Yu Ke; Kai-Lun Liu; Hsing-Pang Hsieh; Guido Bocci; Concettina La Motta
Journal:  Sci Rep       Date:  2019-07-09       Impact factor: 4.379

5.  Apoptosis induced by ursodeoxycholic acid in human melanoma cells through the mitochondrial pathway.

Authors:  Huan Yu; Qi-Rui Fu; Zhi-Jie Huang; Jia-Yu Lin; Qing-Xi Chen; Qin Wang; Dong-Yan Shen
Journal:  Oncol Rep       Date:  2018-10-29       Impact factor: 3.906

6.  Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine.

Authors:  Mona O Mohsen; Monique Vogel; Carsten Riether; Julius Muller; Silvia Salatino; Nicola Ternette; Ariane C Gomes; Gustavo Cabral-Miranda; Aadil El-Turabi; Christiane Ruedl; Thomas M Kundig; Said Dermime; Alexander Knuth; Daniel E Speiser; Martin F Bachmann
Journal:  Front Immunol       Date:  2019-05-15       Impact factor: 7.561

7.  LncRNA HOTAIR Promotes Proliferation of Malignant Melanoma Cells through NF-ϰB Pathway.

Authors:  Jun Wang; Jingxin Chen; Gang Jing; Daoquan Dong
Journal:  Iran J Public Health       Date:  2020-10       Impact factor: 1.429

8.  Overcoming resistance to BRAFV600E inhibition in melanoma by deciphering and targeting personalized protein network alterations.

Authors:  S Vasudevan; E Flashner-Abramson; Heba Alkhatib; Sangita Roy Chowdhury; I A Adejumobi; D Vilenski; S Stefansky; A M Rubinstein; N Kravchenko-Balasha
Journal:  NPJ Precis Oncol       Date:  2021-06-10

9.  Case report of a KIT-mutated melanoma patient with an excellent response to apatinib and temozolomide combination therapy.

Authors:  Cong Luo; Jiayu Shen; Jieer Ying; Xianhua Fang; Xiaohong Wang; Zhixuan Fu; Peng Liu
Journal:  Onco Targets Ther       Date:  2017-09-14       Impact factor: 4.147

10.  Long non-coding RNA AFAP1-AS1 accelerates the progression of melanoma by targeting miR-653-5p/RAI14 axis.

Authors:  Fei Liu; Lanting Hu; Yi Pei; Ke Zheng; Wei Wang; Shenglong Li; Enduo Qiu; Guanning Shang; Jiaming Zhang; Xiaojing Zhang
Journal:  BMC Cancer       Date:  2020-03-30       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.